XML 13 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
COVER - USD ($)
 12 Months Ended
Dec. 31, 2023
Jun. 07, 2024
Jun. 30, 2023
Document Information [Line Items]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Document Transition Report false    
Entity File Number 001-39403    
Entity Registrant Name Abacus Life, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 85-1210472    
Entity Address, Address Line One 2101 Park Center Drive, Suite 200    
Entity Address, City or Town Orlando    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 32835    
City Area Code 800    
Local Phone Number 561-4148    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period true    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 11,651,731
Entity Common Stock, Shares Outstanding   63,984,567  
Amendment Description EXPLANATORY NOTEAbacus Life, In. (the “Company”) is filing this Amendment No. 2 on Form 10-K/A (the “Amended 10-K No. 2”) to amend the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, originally filed with the Securities and Exchange Commission (the “SEC”) on March 21, 2024 (the “Original 10-K”), as amended by that Amendment No. 1 to the Annual Report on Form 10-K/A for the fiscal year ended December 31, 2023 (the “Amended 10-K”), filed with the SEC on May 20, 2024, to update Item 15. to add the Consent of the Independent Registered Public Accounting Firm for their report on the financial statements of Abacus Settlements, LLC, a predecessor of the Company, that was inadvertently omitted from the Amended 10-K and to update the date of the Consent of the Independent Registered Public Accounting Firm for their report on the financial statements of Abacus Life, Inc. originally included in the Amended 10-K. We also updated the number of shares of common stock outstanding as of the latest practicable date on the Cover of the Amended 10-K No. 2.The Company has attached to this Amended 10-K No. 2 updated certifications executed as of the date of this Amended 10-K No. 2 by the Principal Executive Officer and Principal Financial Officer as required by Sections 302 and 906 of the Sarbanes Oxley Act of 2002. These updated certifications are attached as Exhibits 31.1, 31.2, 32.1, and 32.2 to this Amended 10-K No. 2.Except as described above, no other amendments are being made to the Amended 10-K. This Amended 10-K No. 2 does not reflect events occurring after the filing of the Original 10-K or modify or update the disclosure contained therein in any way other than as required to reflect the amendments discussed above.    
Entity Central Index Key 0001814287    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag true    
Common Stock      
Document Information [Line Items]      
Title of 12(b) Security Common stock, par value $0.0001 per share    
Trading Symbol ABL    
Security Exchange Name NASDAQ    
Warrant      
Document Information [Line Items]      
Title of 12(b) Security Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share    
Trading Symbol ABLLW    
Security Exchange Name NASDAQ    
9.875% Fixed Rate Senior Notes due 2028      
Document Information [Line Items]      
Title of 12(b) Security 9.875% Fixed Rate Senior Notes due 2028    
Trading Symbol ABLLL    
Security Exchange Name NASDAQ